Link Pharmachem last traded at ₹27.00 (2026-10-13). Over the past month the stock moved -1.6%, three months the stock moved -3.6%, year the stock moved -23.0%. Its closing range over 52 weeks is ₹22.64 – ₹35.06, with the latest close 23.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate[1]
Business Overview:[1][2] LPCL is engaged in the manufacturing and selling of organic /drug intermediates for Pharma, Agriculture, Cosmetics, Speciality Chemicals, and Veterinary industries.
In the latest quarter (Jun 2026), Link Pharmachem reported sales of ₹8.77 crore (+12.3%) and net profit of ₹0.32 crore (-20.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 8.77 | 0.45 | 5.13 | 0.32 | 0.72 |
| Mar 2026 | 6.59 | -0.24 | -3.64 | -0.41 | -0.92 |
| Dec 2025 | 6.73 | 0.69 | 10.25 | 0.07 | 0.16 |
| Sep 2025 | 6.29 | 0.34 | 5.41 | 0.02 | 0.05 |
| Jun 2025 | 7.81 | 0.64 | 8.19 | 0.40 | 0.90 |
| Mar 2025 | 6.45 | -0.23 | -3.57 | -0.35 | -0.79 |
| Dec 2024 | 5.34 | 0.11 | 2.06 | -0.67 | -1.51 |
| Sep 2024 | 4.80 | -0.30 | -6.25 | -0.31 | -0.70 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -20.7% | -32.7% | -19.7% | -11.8% | +31.0% | +26.0% | +2.2% | +12.3% |
| Operating profit growth | – | -60.7% | -125.3% | +16.4% | – | +527.3% | – | -29.7% |
| Net profit growth | – | -404.5% | -234.6% | +33.3% | – | – | – | -20.0% |
| EPS growth | – | -402.0% | -233.9% | +32.4% | – | – | – | -20.0% |
| OPM % | -6.3% | 2.1% | -3.6% | 8.2% | 5.4% | 10.3% | -3.6% | 5.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Link Pharmachem reported sales of ₹27.43 crore (+7.9%) and net profit of ₹0.08 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 27.43 | 1.45 | 5.29 | 0.08 | 0.18 |
| Mar 2025 | 25.43 | 0.13 | 0.51 | -1.03 | -2.32 |
| Mar 2024 | 29.90 | -0.65 | -2.17 | -1.36 | -3.06 |
| Mar 2023 | 38.76 | 2.72 | 7.02 | 0.65 | 1.46 |
| Mar 2022 | 53.56 | 3.54 | 6.61 | 1.88 | 4.23 |
| Mar 2021 | 34.81 | 3.14 | 9.02 | 1.08 | 2.43 |
| Mar 2020 | 25.47 | 3.42 | 13.43 | 0.95 | 2.14 |
| Mar 2019 | 24.50 | 2.02 | 8.24 | 0.66 | 1.49 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +4.1% | +4.0% | +36.7% | +53.9% | -27.6% | -22.9% | -14.9% | +7.9% |
| Operating profit growth | -27.3% | +69.3% | -8.2% | +12.7% | -23.2% | -123.9% | – | +1015.4% |
| Net profit growth | -41.6% | +43.9% | +13.7% | +74.1% | -65.4% | -309.2% | – | – |
| EPS growth | -41.3% | +43.6% | +13.6% | +74.1% | -65.5% | -309.6% | – | – |
| OPM % | 8.2% | 13.4% | 9.0% | 6.6% | 7.0% | -2.2% | 0.5% | 5.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Link Pharmachem.
Get Free AI Stock Analysis FREE →No recent news available for Link Pharmachem.
Link Pharmachem shares were last quoted at ₹27.00 (+6.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Link Pharmachem has a price-to-earnings (P/E) ratio of -2,835.00 and a price-to-book (P/B) ratio of 0.96. The industry P/E is 54.21.
The 52-week high of Link Pharmachem is ₹41.90 and the 52-week low is ₹21.00.
The market capitalisation of Link Pharmachem is about ₹12.59 crore.
In the latest quarter (Jun 2026), Link Pharmachem reported sales of ₹8.77 crore (+12.3%) and net profit of ₹0.32 crore (-20.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Link Pharmachem has a 3-year ROE of -6.00%, 3-year profit growth of -48.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 52.40% of Link Pharmachem.
Link Pharmachem belongs to the Pharmaceuticals & Drugs sector.